Related Experiment Videos
Hereditary angioedema: its diagnostic and management perspectives
The American Journal of Medicine
|June 1, 1990
Summary
Hereditary angioedema, a genetic disorder from C1 esterase inhibitor deficiency, causes swelling and pain. Early diagnosis and treatment with androgens can prevent severe attacks and complications.
Area of Science:
- Immunology and Genetics
- Complement System Disorders
Background:
- Hereditary angioedema (HAE) is a rare genetic disorder characterized by C1 esterase inhibitor deficiency.
- HAE attacks manifest as swelling, airway obstruction, and gastrointestinal distress, posing significant health risks.
Purpose of the Study:
- To elucidate the genetic and physicochemical basis of hereditary angioedema.
- To outline diagnostic strategies and therapeutic approaches for managing HAE.
Main Methods:
- Review of recent physicochemical and genetic studies on C1 esterase inhibitor.
- Evaluation of diagnostic tests including serum C4 levels, C1 esterase inhibitor immunoassay, and functional assay.
- Assessment of treatment modalities, including short-term prevention and long-term androgen therapy.
Main Results:
- Serum C4 measurement serves as an effective screening tool for HAE.
- Decreased C4 levels necessitate further testing with C1 esterase inhibitor assays (immunoassay and functional assay).
- Functional assays are crucial for identifying specific genetic variants of HAE.
Conclusions:
- Accurate diagnosis of HAE is critical to prevent life-threatening complications like airway obstruction and unnecessary surgeries.
- Timely diagnosis and management, including preventive measures and androgen therapy, can significantly improve patient outcomes and quality of life.